Not exact matches
Important
factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses
on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the
effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the
effect of global economic conditions
on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the
effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or
other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our
other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and
other customers, and the risk of nonpayment by such customers; 13) any adverse impact
on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact
on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or
other security attacks, information technology failures, or
other disruptions; 16) returns
on pension plan assets and the impact of future discount rate changes
on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco
on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and
other aerostructures suppliers; 19) the
effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the
effect of changes in tax law, such as the
effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted
on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the
effect of such changes; 21) any reduction in our credit ratings; 22) our dependence
on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and
other governments
on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest
on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and
other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and
other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among
other things.
These risks and uncertainties include, among
others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and
other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed
on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side
effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk
Factors» in the company's most recent Annual Report
on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available
on the SEC's website at www.sec.gov.
According to an analysis of 2010 data by the Urban Institute, a nonpartisan think tank, the price tag was $ 669 million in direct hospital costs for just that year and $ 174 billion in larger societal costs, which includes disability,
effects on employment, and
other longer - term
factors.
Such risks, uncertainties and
other factors include, without limitation: (1) the
effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among
other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and
factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various
factors, including market conditions and the level of
other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and
other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and
other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the
effect of changes in political conditions in the U.S. and
other countries in which United Technologies and Rockwell Collins operate, including the
effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU,
on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the
effect of changes in tax (including U.S. tax reform enacted
on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among
other things import / export) and
other laws and regulations in the U.S. and
other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the
other conditions to the closing of the pending acquisition
on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative
effects of the announcement or the completion of the merger
on the market price of United Technologies» and / or Rockwell Collins» common stock and / or
on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in
effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or
other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
After controlling for all
other factors, the study found that commuting has a detrimental psychological
effect on women, but not
on men.
Actual results may differ materially from those indicated by these forward - looking statements as a result of various important
factors including, but not limited to, the
effects of any unexpected difficulty in closing our financial books for the quarter and
other factors that are discussed in the Company's Annual Report
on Form 10 - K, quarterly reports
on Form 10 - Q, and
other documents periodically filed with the SEC.
Important
factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among
others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and
other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from
other cancer screening and diagnostic products and services; the
effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the
effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the
other risks and uncertainties described in the Risk
Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form
Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report
on Form 10 - K and our subsequently filed Quarterly Reports
on Form 10 - Q.
Trade specialists agree that it has proven difficult to separate the deal's direct
effects on trade and investment from
other factors, including rapid improvements in technology, expanded trade with
other countries such as China and unrelated domestic developments in each of the countries.
For example, the expected timing and likelihood of completion of the proposed merger, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed merger that could reduce anticipated benefits or cause the parties to abandon the transaction, the ability to successfully integrate the businesses, the occurrence of any event, change or
other circumstances that could give rise to the termination of the merger agreement, the possibility that Kraft shareholders may not approve the merger agreement, the risk that the parties may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all, risks related to disruption of management time from ongoing business operations due to the proposed transaction, the risk that any announcements relating to the proposed transaction could have adverse
effects on the market price of Kraft's common stock, and the risk that the proposed transaction and its announcement could have an adverse
effect on the ability of Kraft and Heinz to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and
on their operating results and businesses generally, problems may arise in successfully integrating the businesses of the companies, which may result in the combined company not operating as effectively and efficiently as expected, the combined company may be unable to achieve cost - cutting synergies or it may take longer than expected to achieve those synergies, and
other factors.
Even though student loans have little
effect on homeownership for most graduates,
other factors should be considered before you buy a house.
One of the most recent published studies and easily to access for free, was conducted by Moro and her colleagues and investigated the
effects of eight weeks of time - restricted feeding
on metabolic
factors, body composition, strength and
other markers in resistance - trained males.
We also have experienced, and may experience in the future, gross margin declines in certain businesses, reflecting the
effect of items such as competitive pricing pressures, inventory write - downs and increases in component and manufacturing costs resulting from higher labor and material costs borne by our manufacturers and suppliers that, as a result of competitive pricing pressures or
other factors, we are unable to pass
on to our customers.
Actual results may vary materially from those expressed or implied by forward - looking statements based
on a number of
factors, including, without limitation: (1) risks related to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail to obtain shareholder approval of the Merger Agreement, (c) the parties may fail to secure the termination or expiration of any waiting period applicable under the HSR Act, (d) other conditions to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger; (3) the effects that the announcement or pendency of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect of limitations that the Merger Agreement places on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with t
factors, including, without limitation: (1) risks related to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail to obtain shareholder approval of the Merger Agreement, (c) the parties may fail to secure the termination or expiration of any waiting period applicable under the HSR Act, (d)
other conditions to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations
on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the
effects that any termination of the Merger Agreement may have
on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling
effect on alternatives to the Merger; (3) the
effects that the announcement or pendency of the Merger may have
on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from
other important matters; (4) the
effect of limitations that the Merger Agreement places
on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and
other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and
others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7)
other economic, business, competitive, legal, regulatory, and / or tax
factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with t
factors; and (8)
other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with t
factors described under the heading «Risk
Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with t
Factors» in Part I, Item 1A of BWW's Annual Report
on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with the SEC.
With no prior 6 - month losses to recover, it seems likely that
other factors will exert a stronger
effect on market returns going forward than if the Fed's easing had been initiated in response to a major low.
These risks and uncertainties include: fluctuations in U.S. and international economies and currencies, our ability to preserve, grow and leverage our brands, potential negative
effects of material breaches of our information technology systems if any were to occur, costs associated with, and the successful execution of, the company's initiatives and plans, the acceptance of the company's products by our customers, the impact of competition, coffee, dairy and
other raw material prices and availability, the
effect of legal proceedings, and
other risks detailed in the company filings with the Securities and Exchange Commission, including the «Risk
Factors» section of Starbucks Annual Report
on Form 10 - K for the fiscal year ended September 28, 2014.
It should also be noted that there have been
other factors, outside of Asian development and the associated large increase in commodity prices and the exchange rate, that have had an
effect on economic activity in Australia.
While we believe that temporary
factors have amplified the drop in services inflation, the ECB will likely worry about potential second - round
effects of lower oil prices and currency appreciation
on the price of some
other (non-energy) goods and services, including
on Non-Energy Industrial Goods inflation which fell sharply, from 0.7 % to 0.3 % in February.
Hi Julie, matcha is finely ground green tea so it could potentially have an
effect on iron absorption at a meal, but research in this area is conflicting meaning there are many
other factors to consider and it's not clear - cut whether there's a significant negative connection with tea consumption and iron levels.
We talk about sharp action often here at The Action Network, but there are
other factors, like injuries, public action, etc., that have significant
effects on the betting market as well.
This study and
others like it help to show that there exists in children's lives a whole spectrum of environmental
factors that fall short of the traditional definition of trauma but still have an adverse
effect on brain development.
While most regular medicines will not have any
effect on baby through breastfeeding, it eventually depends
on a lot of
other factors too (mentioned earlier).
Understand the
effects on test performance of pre-existing neurological conditions (learning disabilities, attention deficit disorder, ADHD) and
other extraneous
factors; and
«The way in which the only child develops is shaped by the same
factor that influences all children — that
factor is the parents, and it can be said boldly that the
effects of parenting are magnified
on the only child because there are no
other children around to dilute those
effects.»
However, bacterial growth may also be a secondary
effect of
other known risk
factors like over-heating, parental smoking and lying a child
on its stomach.
These findings are all consistent with the growing body of literature
on the impact of adverse childhood experiences
on neurological, cognitive, emotional and social development, as well as physical health.38 Although some studies have found no relation between physical punishment and negative outcomes, 35 and
others have found the relation to be moderated by
other factors, 12 no study has found physical punishment to have a long - term positive
effect, and most studies have found negative
effects.17
Thus, for these studies there is a clear reliance
on either matching or statistical adjustment for the
effects of
other factors correlated with feeding method that may also influence child outcomes such as maternal IQ and / or parenting style.
Under the Kavanagh / Squadron bill, the
factors applicable to all license applications would include the number, type, and proximity of
other licenses in the area; whether the applicant has necessary permits; the potential
effect of the license
on traffic and parking; noise levels; any history of liquor violations or criminal activity at the premises; any history of building and fire violations at facilities operated or owned by the applicant; and any formal communications about the application from the municipality or community board.
Differential turnout
on the
other hand will be a major
factor — it was for Jon Cruddas in the last deputy election where some union leaders worked hard to get his vote out (which is why I think the
effect of the recommendation is only «arguable»).
However, scientists suspect these studies do not reflect the true
effect of BMI
on health, because early stages of illness, health - damaging behaviours, such as cigarette smoking, and
other factors can lead to both lower BMI and increased risk of death.
As a result, estimates of coastal vulnerability — which once focussed
on sea level rise — now have to
factor in changing patterns of storm erosion, more intense storms, and
other coastal
effects.
«We see better potential transmission at these lower temperatures,» says Paaijmans, although he adds that the
effect of temperature
on other factors, such as mosquito biting rate, still needs to be explored.
The setting gave scientists the rare opportunity to look at the impact of pollution
on atmospheric processes in a largely pre-industrial environment and pinpoint the
effects of the particles apart from
other factors such as temperature and humidity.
«These are the first studies to show that exercise can have an
effect on your gut independent of diet or
other factors,» said Jeffrey Woods, a University of Illinois professor of kinesiology and community health who led the research with former doctoral student Jacob Allen, now a postdoctoral researcher at Nationwide Children's Hospital in Columbus, Ohio.
«The
effect on the splicing
factors and
other mutations associated with leukemia was completely surprising to me,» Klein said.
The study focused
on the possible
effects of depression and
other factors on bone health.
It's not yet clear whether calcium carbonate has a direct detrimental
effect on the skin barrier, or whether
other environmental
factors directly related to water hardness, such as the water's pH, may be responsible.»
Daintree is just one of the sites in Australia's Terrestrial Ecosystem Research Network (TERN), an information - sharing organization that collects, manages, and shares data
on flora, fauna, and
other environmental
factors to capture snapshots of what key wilderness ecosystems look like now and measure the potential
effects of climate change.
Maharaj said he chose to use G - CSF because he thinks it's the best way to mobilize the proteins and
other factors into young plasma that he thinks could have a restorative
effect on the older participants.
But in the current issue of the Journal of the American Medical Association, Elizabeth Barrett - Connor and colleagues at the University of California, San Diego, describe how they found that the
effect of drinking coffee
on bone density in women was independent of
other factors such as smoking and exercise.
Other factors analysed (including avoidance of activity, damage beliefs and catastrophizing) were weaker mediators of the
effects on fatigue and physical function.
The
effects of sauna bathing
on the risk of Alzheimer's disease and
other forms of dementia were studied in the Kuopio Ischaemic Heart Disease Risk
Factor Study (KIHD), involving more than 2,000 middle - aged men living in the eastern part of Finland.
The Nicaraguan study is the first to demonstrate that educating women has a direct
effect on their children's health and that this has nothing to do with these
other factors.
The
effects of PTSD
on heart disease remained strong even after researchers accounted for lifestyle
factors such as smoking, physical activity level, and drinking; and major depression and
other psychiatric diagnoses.
Scientists studying the potential
effects of climate change
on the world's animal and plant species are focusing
on the wrong
factors, according to a new paper by a research team from the Wildlife Conservation Society, University of Queensland, and
other organizations.
It is uncertain whether
other school districts can replicate these
effects, because they depend
on factors that many have little control over (including the local supply of high - performing teachers), as well as those they do control (for instance, the introduction of meaningful teacher evaluation).
The drug Gefitinib is used to treat breast, lung, and
other cancers by inhibiting epidermal growth
factor receptor (EGFR) signaling, but it has only a limited
effect on prostate cancer.
This is an observational study so no firm conclusions can be drawn about cause and
effect, and no data
on other potentially influential
factors, such as lifestyle and family history, were available, say the researchers.
The authors note that although the
effect of maternal obesity
on cerebral palsy may seem small compared with
other risk
factors, the association is of public health relevance due to the large proportion of women who are overweight or obese.
Overall, the researchers found that about 76 percent of the
effect of ethnicity
on DNA methylation could be accounted for by controlling for genetic ancestry, suggesting that nearly a quarter of the
effect must be due to
other, unknown
factors.
Even when Bero controls for a variety of
other factors, she finds that the
effect of industry funding
on the research outcome is huge.